Clinical trial
Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV…
NCT00449163 · University of Miami, Other · Terminated
Key facts
| NCT number | NCT00449163 |
|---|---|
| Title | Combination Chemotherapy and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer |
| Official title | Phase II Study of Avastin, Irinotecan, High Dose 24 Hour Continuous Intravenous Infusion of Floxuridine and Leucovorin in Patients With Previously Untreated Metastatic Colorectal Cancer |
| Lead sponsor | University of Miami, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Colorectal Cancer |
| Intervention type | Biological, Drug |
| Interventions | Bevacizumab, Floxuridine, Irinotecan, Leucovorin |
| Enrollment | 25 |
| Start date | Mar 1, 2006 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | Mar 19, 2007 |
| Last update posted | May 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: